Table 1

Demographic, clinical and laboratory findings in groups I and II

2000–20152000–2012 (inpatients)2012–2015 (outpatients)p Value
Biopsies462333129
Passages, mean±SD/median (range)2.6±0.7/3 (1–5)2.9±0.6/3 (1–5)3.1±0.6/3 (2–5)NS
Glomeruli, mean±SD/median (range)19.9±11.3/18 (6–71)21.6±12.4/20 (1–71)23.9±12/23 (3–58)0.01
Age, mean±SD54.7±17.956±1952±17.6NS
Female, n (%)180 (39)114 (34)66 (51)NS
Admission duration (days), mean±SD/median (range)1.1±0.6/1 (1–7)
sCr (mg/dL), mean±SD/median (range)1.67±1.2/1.3 (0.5–7)1.56±0.9/1.3 (0.5–6)1.8±1.24/1.4 (0.5–7)NS
sCr >3 (mg/dL), n (%)124 (26.8)89 (29.6)35 (27.1)NS
Proteinuria (g/24 hours), mean±SD/median (range)2.6±2.3/2 (0.0–13)2.7±2.2/2 (0.0–10)2.6±2.2/2 (0.2–13)NS
Prebiopsy haematuria, n (%)375 (81.2)261 (78.4)114 (88.4)0.01
Resistant hypertension*, n (%)110 (23.9)93 (27.9)17 (13.2)0.008
Complications (any), n (%)36 (7.8)24 (7.2)12 (9.3)NS
Minor, n (%)27 (5.8)19 (5.7)8 (6.2)NS
Major, n (%)9 (1.9)5 (1.5)4 (3.1)NS
  • *Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281–357.